Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

SQI Diagnostics Inc. (V:SQD)

Business Focus: Advanced Medical Equipment & Technology (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for SQD within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 02, 2022 07:19 ET
SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/
Read full article
Nov 24, 2022 16:19 ET
SQI Diagnostics Inc. Announces Private Placement of $1.0 Million
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.17
--
--
Price to Sales - TTM
5.31
6.95
4.47
Price to Book - most recent quarter
--
2.93
1.67
Price to Cash Flow per share - TTM
--
27.71
9.11
Price to Free Cash Flow per share - TTM
--
2.14
12.54
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 202237,222-19,435
Nov 15, 202256,65740,107
Oct 31, 202216,55012,446
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

SQI Diagnostics Inc. discovers, develops, and commercializes diagnostic testing for healthcare professionals, patients and consumers. The Company develops and manufactures respiratory health and precision medicine tests that run on structured query language (SQI) fully automated systems. Its tests enhance COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its COVID-19 testing solutions include Rapid Mobile PCR Testing for COVID-19, Sofia SARS Antigen Fluorescent Immunoassay (FIA) and Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA). Its transplant diagnostics solutions include TORdx LUNG Test, which is a diagnostic that assesses the health of donor lungs, and Ex Vivo Lung Perfusion provides care for conditioning donor lungs suspected of injury prior to transplantation. It also offers surveillance testing such as Celiac Disease Screening Test and Rheumatoid Arthritis Test.

See business summary

 

Twitter

Search (past week) for $SQD.CA SQD.V

  • No tweets found